Agrylin Drug Use-Result Survey
NCT03625895
·
clinicaltrials.gov ↗
COMPLETED
Status
1826
Enrollment
INDUSTRY
Sponsor class
Conditions
Essential Thrombocythemia (ET)
Sponsor
Takeda